Medical devices; clinical chemistry and clinical toxicology devices; classification of the breath nitric oxide test system. Final rule.
The Food and Drug Administration (FDA) is classifying the breath nitric oxide test system into class II (special controls). The agency is taking this action in response to a petition submitted under the Federal Food, Drug, and Cosmetic Act (the act) as amended by the Medical Device Amendments of 1976 (the 1976 amendments), the Safe Medical Devices Act of 1990 (the SMDA), and the Food and Drug Administration Modernization Act of 1997 (FDAMA). The agency is classifying this device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device. Elsewhere in this issue of the Federal Register, FDA is announcing the availability of a guidance document that will serve as the special control for the device.
D001944:Breath Tests / Q000295:instrumentation*; D019963:Clinical Chemistry Tests / Q000145:classification; D018795:Device Approval / Q000331:legislation & jurisprudence; D004869:Equipment Safety / Q000145:classification*; D006801:Humans; D007883:Legislation, Medical; D009569:Nitric Oxide / Q000145:classification*; D014116:Toxicology / Q000145:classification / Q000295:instrumentation; D014481:United States; D014486:United States Food and Drug Administration
D009569:Nitric Oxide